About this item:

480 Views | 415 Downloads

Author Notes:

Email: Aashraf@peds.uab.edu

Conceived and designed the experiments: APA JAA BAG.

Performed the experiments: APA JAA TD DC.

Analyzed the data: APA RG LJH XW.

Contributed reagents/materials/analysis tools: DC TD XW BAG.

Wrote the paper: APA JAA LJH TD BAG.

Study design: APA JAA BAG.

Study conduct: APA JAA.

Data collection: APA JAA TD DC.

Data analysis: APA RG LJH XW.

Data interpretation: APA JAA LJH BAG TD DC.

Drafted manuscript: APA JAA LJH TD.

Revised manuscript content: APA JAA LJH TD.

Approved final version of manuscript: APA.

The authors thank the staff and subjects of the clinical trials for their valuable contributions.

This study included the clinical trial, NCT01041365.

Competing Interests: The authors have declared that no competing interests exist.

Subjects:

Research Funding:

This work was supported by funding to AA through Child Health Research Center Grant K12 HD043397 T0909180013, National Center for Advancing Translational Research of the National Institutes of Health (UL1TR00165), NORC core lab (P30DK56336) and DRTC core lab (P60DK079626).

JAA also received funding through the American Heart Association (Greater Southeast Affiliate).

The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Keywords:

  • Science & Technology
  • Multidisciplinary Sciences
  • Science & Technology - Other Topics
  • VITAMIN-D STATUS
  • FLOW-MEDIATED VASODILATION
  • EXPERT CONSENSUS DOCUMENT
  • PULSE-WAVE VELOCITY
  • D-BINDING PROTEIN
  • ARTERIAL STIFFNESS
  • BLOOD-PRESSURE
  • INSULIN-RESISTANCE
  • RACIAL-DIFFERENCES
  • SUPPLEMENTATION

Associations between Vascular Health Indices and Serum Total, Free and Bioavailable 25-Hydroxyvitamin D in Adolescents

Tools:

Journal Title:

PLoS ONE

Volume:

Volume 9, Number 12

Publisher:

, Pages e114689-e114689

Type of Work:

Article | Final Publisher PDF

Abstract:

Objective The role of vitamin D in cardiovascular health remains debated as results have been inconsistent. Previous studies have not considered the bioavailability of 25-hydroxy vitamin D [25(OH)D]. Objectives of our study were to investigate the association between serum concentrations of total, free and bioavailable 25(OH)D and independent predictors of cardiovascular risk such as flow mediated dilatation (FMD) and augmentation index (AIx). Design This cross-sectional study included 47 post-menarchal, adolescent females [31 African American (AA) and 16 European American (EA)]. Methods AIx was standardized to a heart rate of 75 beats/min (AIx75). Free and bioavailable 25(OH)D concentrations were calculated from standard formulas. Results and Conclusions Mean age of the participants was 15.8±1.4 years and mean body mass index was 23.1±4.0 kg/m2. Serum total 25(OH)D was not associated with FMD, but was positively associated with AIx75 in the adjusted model (rho = 0.4, P = 0.03). AIx75 was positively associated with bioavailable 25(OH)D (rho = 0.4, P = 0.004) and free 25(OH)D (rho = 0.4, P = 0.009) and the associations persisted after adjusting for covariates. In race-specific analyses, total, free and bioavailable 25(OH)D were strongly positively associated with AIx75 in AA (rho = 0.5, 0.4, 0.4, respectively), which persisted even after adjusting for covariates. Whereas in EA there was an inverse association between total 25(OH)D and AIx75 in EA (rho = −0.6), which attenuated after adjusting for covariates. Conclusion Circulating total, free and bioavailable 25(OH)D were associated with arterial stiffness in adolescent girls, and these associations were race dependent. Notwithstanding, the implications of associations between vascular function indices and 25(OH)D remains unclear.

Copyright information:

© 2014 Ashraf et al.

This is an Open Access work distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/).
Export to EndNote